In multiple myeloma, a high-dose conditioning treatment prior to stem cell transplant
Prescribing Information Important Safety Information

    Lorem ipsum dolor sit amet

    Home / Faq / Lorem ipsum dolor sit amet

    Lorem ipsum dolor sit amet

    Lorem ipsum dolor sit amet, soleat vulputate has et, tempor audiam eum ex. Mutat apeirian vel ei, usu et esse efficiantur, no eum graecis corpora. Ea utamur fastidii duo, adhuc prodesset conclusionemque eam ad. Ea ius audire nostrum accusamus, in vim nulla causae accumsan, an debet habemus phaedrum eos. Tritani civibus ex pri, id vel magna veritus, eos eu vide decore nonumes. Id quo mazim blandit delectus, ei inani possit ullamcorper mea.

    About the Author

    starklogic
    Important Safety Information
    Click to Hide Advanced Floating Content
    Important Safety Information
    Warnings and Precautions

    Bone Marrow Suppression: For patients receiving EVOMELA as part of a conditioning regimen, myeloablation occurs in all patients. Do not begin the conditioning regimen if a stem cell product is not available for rescue. Monitor complete blood counts, provide supportive care for infections, anemia and thrombocytopenia until there is adequate hematopoietic recovery.

    See More